Q4 2023 Holdings
Filed 2024-02-14 | 32 holdings | $1.1B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-02-14) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $130.6M | 4,747,373 | 11.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $99.8M | 2,167,793 | 8.7% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $98.0M | 1,331,037 | 8.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $83.8M | 5,450,000 | 7.3% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $71.3M | 1,550,000 | 6.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $69.1M | 1,100,000 | 6.0% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $43.1M | 1,900,000 | 3.8% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $42.1M | 1,000,000 | 3.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $41.9M | 1,924,074 | 3.7% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $41.2M | 1,000,000 | 3.6% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $40.5M | 1,884,084 | 3.5% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $40.2M | 2,901,816 | 3.5% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $32.7M | 5,566,026 | 2.9% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $30.7M | 1,610,000 | 2.7% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $28.2M | 700,000 | 2.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $27.8M | 701,967 | 2.4% |
| Celcuity Inc(CELC) | COM | 15102K100 | $25.6M | 1,754,704 | 2.2% |
| Rayzebio Inc | COM | 75525N107 | $23.9M | 383,638 | 2.1% |
| Pharvaris N V(PHVS) | COM | N69605108 | $22.4M | 800,000 | 2.0% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $21.5M | 3,800,000 | 1.9% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $20.3M | 1,895,003 | 1.8% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $18.0M | 2,730,000 | 1.6% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $17.9M | 1,248,062 | 1.6% |
| Harpoon Therapeutics Inc | COM NEW | 41358P205 | $17.1M | 1,500,000 | 1.5% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $13.2M | 565,000 | 1.2% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $12.0M | 900,000 | 1.0% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $8.1M | 1,575,000 | 0.7% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $7.8M | 706,706 | 0.7% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $7.5M | 10,000,000 | 0.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $7.0M | 250,000 | 0.6% |
| SAB Biotherapeutics Inc(SABS)A | COM | 78397T202 | $1.3M | 1,831,746 | 0.1% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $88.3K | 92,687 | 0.0% |